At COP29 Politicians Are Talking About Climate Change. Here’s What’s Happening.
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
- Science
Pam Belluck
- 0
- 1 minute read
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
